Dr. Roger D. Klein, MD,JD is an expert in Health and Law with the Regulatory Transparency Project’s FDA and Health working group. He is a former Medical Director of Molecular Pathology at the Cleveland Clinic and former adviser to the FDA, CDC, HHS and CMS.
Biden’s policy change and how it will effect Americans and access to the life saving to buprenorphine. The Opioid crisis continues to take its toll on the American people. Yet the Biden administration policy change [1] has made it more difficult for Doctors to prescribe drugs which have worked wonders in recovering addicts.